"By working with distinguished experts as
luminary partners in fields such as CT angiography and colonography,
musculoskeletal imaging and MRI breast imaging, Toshiba is able to
ensure that our equipment is clinically relevant and that the
technologies meet the latest imaging requirements to perform advanced
CT and MRI procedures."
Faculty speakers at the Snowmass 2005 symposia are Mark H. Toshiba Corp. is a leader in information
and communications systems, electronic components, consumer products,
and power systems.
Pfenex Expression Technology(TM) is built around specially modified
strains of Pseudomonas fluorescens bacteria that increase cellular expression
of recombinant proteins and peptides while maintaining critical solubility and
activity characteristics. With annual sales of $40 billion, Dow serves customers in 175
countries and a wide range of markets that are vital to human progress: food ,
transportation, health and medicine, personal and home care, and building and
construction, among others.

combating malaria

Clouse will present on
coronary artery calcification, CT coronary arteriography. For more information on Dowpharma, visit http://www.com.

tropical actm

tropics wellcome

20-25, 2005., professor of diagnostic radiology, Division of Chest
and Cardiovascular Imaging, University of Iowa; Mark L. Awh is presenting on MRI of the foot, ankle, hand, wrist and
knee.

combating headings

, and Doug Ryan, director, CT Business Unit,
Toshiba America Medical Systems Inc. Dolmatch will discuss CT findings on the aorta and CTA of
the lower extremity and measurements. Stanford will provide insights on
the role of CT in cardiac imaging, epidemiology of heart disease and
CT evaluation of pulmonary emboli., an
independent group company of Toshiba Corp.dow. For more information on Iomai,
please visit http://www.

The branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions.

subtropical infectious

D.
Dr. Dr.

gorgas tropics

"As a leader in the clinical development of CT and MRI
technologies for both radiology and cardiology applications, Toshiba
is dedicated to working with medical professionals who are equally
focused on advancing the use of CT and MRI to expand and improve
healthcare," said John Zimmer, vice president , marketing, Toshiba
America Medical Systems Inc., president, Radsource (Nashville, Tenn. Winkler will discuss
multi-detector MRI technology, patient-focused MRI, as well as MRI of
the breast and MRI of the lumbar spine. Toshiba has approximately 161,000 employees
worldwide and annual sales of $53 billion.
Under the terms of the agreement, Iomai will employ the Pfenex Expression
Technology (TM) for the production of heat labile enterotoxin (LT), a key
component of Iomai's transcutaneous immunization platform technology for the
delivery of vaccines to the skin."
"We are in Phase II clinical trials with our ETEC vaccine to treat
travelers' diarrhea," said Stanley C. References to "Dow" or the
"Company" mean The Dow Chemical Company and its consolidated subsidiaries
unless otherwise expressly noted.

bacterial tropical

D. Winkler, M. Dr., is a global leading
provider of diagnostic medical imaging systems and comprehensive
medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine ,
MRI and information systems.

Dowpharma(SM) Announces Commercial License Agreement for Pfenex Expression Technology(TM) With Iomai Corporation

diarrhea tropics

D. Mr. Iomai will initially produce LT for use as
a vaccine to treat enterotoxigenic Escherichia coli (ETEC), the most common
cause of acute diarrhea among travelers to developing countries. The Pfenex
expressed LT will be used in subsequent vaccines that will be delivered using
Iomai's transcutaneous immunization technology. Additional
financial details of the agreement were not disclosed.

itg bacterial

D. Dr.
Giegerich and Mr.
"This agreement validates the biopharmaceutical industry's need to produce
therapeutic proteins using an expression system that delivers higher yields
and provides a faster route through process development to reduce the overall
cost of goods for vaccines or biotherapeutics," said Nick Hyde, business
director, Dowpharma.

tropical epidemiology

D. Clouse, M. Dr."

About Dowpharma
Dowpharma(SM) contract manufacturing services serves the pharmaceutical
and biopharmaceutical industries with innovative technologies, products, and
services in drug discovery, development, delivery and manufacturing.

(SM)Service Mark of The Dow Chemical Company
(TM)Trademark of The Dow Chemical Company

headings tropical

Ryan will together address the future directions in
MRI and CT. We're looking forward to
working with the team at Dowpharma and leveraging their experience and
knowledge to enhance our process development activities and to smooth our
ultimate transition into manufacturing with this product.

tropics parasitology

Awh,
M.); Bart L. Raptopoulos will be instructing attendees on his experience
with MDCT in acute abdominal pain, MDCT of the liver and pancreas, CT
colonography and CT angiography. Committed to the principles of sustainable
development , Dow and its 43,000 employees seek to balance economic,
environmental and social responsibilities . For more information on The Dow Chemical
Company, visit http://www.

combating diarrhea

D.);
Vassilios Raptopoulos , M.

About Toshiba

With headquarters in Tustin, Toshiba America Medical Systems
markets , sells, distributes and services diagnostic imaging systems,
and coordinates clinical diagnostic imaging research for all
modalities in the United States.

Erck, President + Chief Executive
Officer at Iomai. With over
three decades of experience, Dowpharma combines the resources and capabilities
of several offerings to create a single-market-focused organization with broad
service and support capabilities for large and emerging pharmaceutical
companies.
Iomai has evaluated skin immunization techniques in several human clinical
trials, including those to prevent influenza in the healthy adult and elderly
populations, and also to prevent travelers' diarrhea and anthrax infection.

altruis tropical

El-Khoury, M.

National Library of Medicine - Medical Subject Headings-2000 MeSH

headings australasian

MIDLAND, Mich. The deal consists of
milestone payments and commercial royalties on product sales .
Bringing Pfenex and Iomai's technologies together will allow Iomai to
economically manufacture better vaccines for the prevention and treatment of
infectious disease.

About Dow
Dow is a leader in science and technology, providing innovative chemical,
plastic and agricultural products and services to many essential consumer
markets.iomai.

mcgill infectious

----Demonstrating its
ongoing commitment to advancing the use of the latest computed
tomography (CT) and magnetic resonance imaging (MRI) technologies,
Toshiba America Medical Systems Inc., Feb. Dolmatch, M. Dr.

australasian subtropical

, professor of radiology and orthopedics and chief,
Musculoskeletal Section, Department of Radiology, University of Iowa
Hospitals and Clinics; John F. Feller, M.com.com.

parasitology malaria

Snowmass 2005 is planned and organized by Educational Symposia and
is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to sponsor continuing medical education for
physicians., vice chair radiology, director of
radiology research , Beth Israel Deaconess Medical Center, deaconess
professor of radiology, Harvard Medical School.

Toshiba speakers
include Bob Giegerich, director, MRI Business Unit, Toshiba America
Medical Systems Inc.,
Dowpharma(SM) contract manufacturing services, a business unit of The Dow
Chemical Company , today announced that it has entered into a commercial
license agreement with Iomai Corporation for Dowpharma's Pfenex Expression
Technology(TM), a Pseudomonas-based technology that accelerates speed to
market for vaccines and biotherapeutics by surpassing the quality and yield
capabilities of existing microbial expression systems. "In the studies we have conducted, Pfenex consistently
outperforms other commercially available microbial expression systems such as
E. Pfenex will enable improved production of Iomai's heat-labile
enterotoxin, a molecule that historically has been very difficult to express.

eminent virology

(TAMS) announces its corporate
support of "Snowmass 2005: Imaging with CT and MRI," an educational
symposia held in Snowmass Village, Colo.dowpharma.
The company has an exclusive, worldwide license to TCI and has confirmed the
potential of TCI in multiple clinical trials.

panajachel bacterial

,
professor of radiology and director of interventional radiology,
University of Texas - Southwestern Medical Center (Dallas); Georges Y.,
adjunct professor, Department of Health Physics, University of Nevada ,
and founding partner, Steinberg Diagnostic Medical Imaging (Las
Vegas); and Melvin E. Dr. Feller
is leading several sessions including topics on MRI of bone marrow,
sports injuries of the shoulder and MRI of the hip.
Dr.

tropical parasitology

Toshiba Supports Educational Symposia on the Latest CT and MRI Developments at Snowmass 2005

Business Editors/Health/Medical Writers
Snowmass 2005

TUSTIN, Calif. The
conference features faculty from several of the country's leading
medical institutions who will discuss a range of topics focused on the
development and implementation of protocols for cardiology and
radiology diagnostic imaging procedures. "We believe that Pfenex will enable us to increase the
expression of our protein and deliver higher yields to support the advancement
of our ETEC vaccine towards regulatory approval.

headings eminent

, assistant clinical
professor of radiology, Stanford University Medical Center, and
medical director, Desert Medical Imaging (Indian Wells, Calif., professor of radiology, Harvard Medical
School, and associate radiologist-in-chief and director of CT
services , Beth Israel Deaconess Medical Center (Boston); William
Stanford, M. El-Khoury will examine
multislice CT of pelvic and acetabular fractures, imaging of upper
extremity, cervical spine and thoraco-lumbar spine traumas. and GAITHERSBURG, Md.

About Iomai Corporation
Founded in 1997, Iomai Corporation is a private biopharmaceutical company
that has pioneered the delivery of vaccines and immunostimulants to the skin
through a proprietary technology known as transcutaneous immunization , or TCI.